• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Agilent Technologies (NY:A)

    153.84 -3.85 (-2.44%)
    Official Closing Price Updated: 7:00 PM EDT, Aug 28, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Agilent Technologies

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    28 29 Next >
    News headline image
    A Q2 Deep Dive: Product Momentum, China Recovery, and Operating Leverage Drive Results
    Life sciences tools company Agilent Technologies (NYSE:A) announced better-than-expected revenue in Q2 CY2026, with sales up 8.1% year on year to $1.88 billi... 
    Via StockStory
    News headline image
    A Look Back at Business Process Outsourcing & Consulting Stocks’ Q2 Earnings: Aramark (NYSE:ARMK) Vs The Rest Of The Pack
    Looking back on business process outsourcing & consulting stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Aramark (NYSE:A... 
    Via StockStory
    Topics Artificial Intelligence Economy
    News headline image
    Agilent Technologies Q3 Earnings Call Highlights ↗
    Agilent Technologies (NYSE:A) reported third-quarter fiscal 2026 revenue of $1.88 billion, with core revenue growth of 7.3%, exceeding the high end of its guidance range. The company said earnings per... 
    Via MarketBeat
    Topics ETFs Earnings World Trade
    News headline image
    Agilent Technologies Q3 2026 Earnings Call: Complete Transcript ↗
    Agilent Technologies (NYSE:A) released third-quarter financial results and hosted an earnings call on Wednesday. Read the complete transcript below. This content is powered by Benzinga APIs. For... 
    Via Benzinga
    Topics Earnings
    Agilent Technologies (NYSE:A) Shows Strong Breakout Setup with Top-Tier Technical Ratings ↗
    Via Chartmill
    Agilent Technologies Inc (NYSE:A): A Quality Growth Play Passes the ‘Caviar Cruise’ Screen ↗
    Via Chartmill
    Stay updated with the S&P500 stocks that are on the move in today's after-hours session. ↗
    Via Chartmill
    News headline image
    Agilent (NYSE:A) Posts Better-Than-Expected Sales In Q2 CY2026, Full-Year Outlook Slightly Exceeds Expectations
    Life sciences tools company Agilent Technologies (NYSE:A) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 8.1% year on year ... 
    Via StockStory
    News headline image
    Agilent Reports Third-Quarter Fiscal Year 2026 Financial Results
    From Agilent Technologies Inc.
    Via Business Wire
    News headline image
    Earnings To Watch: Agilent (A) Reports Q2 Results Tomorrow
    Life sciences tools company Agilent Technologies (NYSE:A) will be reporting results tomorrow after the bell. Here’s what investors should know. Agilent beat ... 
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    2 Stocks Under $50 on Our Watchlist and 1 That Underwhelm
    The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha... 
    Via StockStory
    News headline image
    Agilent Research Catalyst Award Presented to Eastern Institute of Technology, Ningbo
    From Agilent Technologies Inc.
    Via Business Wire
    News headline image
    Agilent to Announce Third-Quarter Fiscal Year 2026 Financial Results on Aug. 26
    From Agilent Technologies Inc.
    Via Business Wire
    News headline image
    1 Healthcare Stock to Research Further and 2 We Avoid
    From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry... 
    Via StockStory
    News headline image
    Agilent Receives EU Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma
    From Agilent Technologies Inc.
    Via Business Wire
    Get insights into the top movers in the S&P500 index of Tuesday's pre-market session. ↗
    Via Chartmill
    News headline image
    Online Retail Stocks Q1 Highlights: Revolve (NYSE:RVLV)
    The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a... 
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    1 of Wall Street’s Favorite Stocks on Our Buy List and 2 We Brush Off
    The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f... 
    Via StockStory
    News headline image
    Agilent Receives FDA Approval for PD-L1 IHC 28-8 pharmDx in Esophageal Squamous Cell Carcinoma (ESCC), Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinoma
    From Agilent Technologies Inc.
    Via Business Wire
    News headline image
    Agilent (A): Buy, Sell, or Hold Post Q1 Earnings?
    Over the past six months, Agilent’s stock price fell to $134.31. Shareholders have lost 8.2% of their capital, which is disappointing considering the S&P 500... 
    Via StockStory
    Topics Stocks
    News headline image
    Agilent Expands Altura Portfolio with Inert Size Exclusion and PLRP-S Columns for Biotherapeutic Analysis
    From Agilent Technologies Inc.
    Via Business Wire
    News headline image
    Agilent Launches AI-Driven Analysis Module for Agilent xCELLigence RTCA eSight
    From Agilent Technologies Inc.
    Via Business Wire
    News headline image
    Agilent (A) Stock Trades Up, Here Is Why
    What Happened? Shares of life sciences tools company Agilent Technologies (NYSE:A) jumped 3.9% in the morning session after it announced the completion of it... 
    Via StockStory
    News headline image
    Agilent Completes Acquisition of Biocare Medical
    From Agilent Technologies Inc.
    Via Business Wire
    News headline image
    Research Tools & Consumables Stocks Q1 Results: Benchmarking Agilent (NYSE:A)
    As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q1. Today, we are looking a... 
    Via StockStory
    Topics Economy
    News headline image
    3 Large-Cap Stocks We Keep Off Our Radar
    Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it m... 
    Via StockStory
    News headline image
    1 Profitable Stock to Target This Week and 2 We Avoid
    Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ... 
    Via StockStory
    News headline image
    Dow, S&P 500, Nasdaq: A Clear Guide to America’s Core Stock Market Indices ↗
    Dow, S&P 500, NasdaqThe Dow Jones Industrial Average, the S&P 500, and the Nasdaq Composite are the three most widely tracked stock market indices in the U 
    Via Talk Markets
    Topics Artificial Intelligence Economy Retirement
    News headline image
    Agilent, OpenAI, BCG Collaborate to Accelerate Customer-Focused, AI-Driven Scientific Innovation
    From Agilent Technologies Inc.
    Via Business Wire
    News headline image
    The 5 Most Interesting Analyst Questions From Agilent’s Q1 Earnings Call
    Agilent’s second quarter saw a positive market reaction, underpinned by broad-based revenue growth and notable operating margin expansion. Management credite... 
    Via StockStory
    Topics Earnings
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    28 29 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.